Skip to main content

Document language

Encontrados 1734543 resultado(s)
Encontradas 17346 página(s)

Ciltacabtagene Autoleucel (Cilta-cel) vs Standard of Care (SOC) in Patients With Lenalidomide (Len)-Refractory Multiple Myeloma (MM) After 1-3 Lines of Therapy: Minimal Residual Disease Negativity (MRD-neg) in the Phase 3 CARTITUDE-4 Trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Einsele, H, Oriol, A, Popat, R, Cavo, M, Karlin, L, Avivi, L, Roelofzen, W, Kim, SJ, Lipe, B, Bar, N, Horvath, N, Spencer, A, Min, CK, Chen, D, Li, Q, Li, K, Slaughter, A, Lonardi, C, Benachour, N, Ghosh, A, Vogel, M, Lendvai, N, Lengil, T, Patel, N, Costa, O, Florendo, E, Lin, Y




Ethanol ablation cost in the United States: An abusive manipulation of drug regulations

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Lopez-Martinez, H, Bisbal, F, Rodriguez-Manero, M, Derval, N, Pambrun, T, De Waroux, JBL, Knecht, S, Duytschaever, M, De Smet, M, Baran, J, Sáenz-Morales, LC, Tapias, C, Giraldo, S, Cordero-Cabra, A, Lara-Vaca, S, Korolev, S, Kim, SH, Valderrabano, M




Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Francesqui, J, Ramos, D, Bollo, E, Villar, A, Flórez, P, Balcells, E, Castaño, G, Pinillos-Robles, EJ, Godoy, R, López-Muñiz, B, Soler-Sampere, MJ, Castillo, D, Rafecas, A, Mariscal, P, Millan-Billi, P, Portillo, K, Hernandez-Gonzalez, F, Sellares, J




Phase Ib-II trial of tumor-loaded monocyte-derived dendritic cell vaccination plus atezolizumab in ES-SCLC

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Cao, MG, Sistere, M, Bueno, MTM, Reguart, N, Meyerhans, A, Cabezon, R, Hernandez, AA, Roman, R, Molina-vila, MA, Birgin, K, Domenjo, E, Pique, G, Horno, IM, Cirera, L, Esparre, C, Drozdowskyj, A, Martinez, E, Rosell, R, Otero, MJ, Benitez-Ribas, D




Lineage-specific distribution of clonal hematopoiesis of indeterminate potential across mature hematopoietic subpopulations in cancer patients

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Gonzalez, AP, Jou, CP, Acha, P, Corres, IS, Garces, VN, Palomo, L, Martinez, SD, Zamora, E, González, NS, Baraibar, I, Madrid, LF, Braña, I, Beas, F, Jáuregui, SN, Torres-Esquius, S, Calvete, O, Francesc Solé, Ezponda, T, Alfonso-Pierola, A, Del Rey, M, Diez-Campelo, M, Montoro, MJ, Valcarcel, D




Posture-dependent changes in left atrial pressure: insights from the VECTOR-HF studies

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Koren, O, Frydman, S, Del Trigo, M, Amat-Santos, IJ, Bayes-Genis, A, Schewel, D, Wiese, A, Manhal, H, Caspi, O, Nunez, J, Petriashvili, S, Kurashvili, L, Metreveli, M, Abraham, WT, Perl, L




Myocardial Dysfunction in Primary Mitral Regurgitation

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Anand, V, Bonow, RO, Nishimura, RA, Delgado, V, Cavalcante, JL, Puthumana, JJ, Narang, A, Hung, JW, Thomas, JD, Ranard, LS, Rigolin, VH

This narrative review describes current guidelines for intervention in severe primary mitral regurgitation and explores an approach that incorporates additional injury assessment, novel imaging markers, and biomarkers to optimize surgical timing. ImportancePrimary mitral regurgitation (MR) is a prevalent valvular lesion. Current American College of Cardiology/American Heart Association guidelines include class I recommendations for intervention for severe primary MR at the onset of symptoms,…



Unraveling clonal hematopoiesis of indeterminate potential (CHIP) in cancer: Prevalence, clonal dynamics, and prognostic significance.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
González, AP, Jou, CP, Acha, P, Navarro, V, Palomo, L, Calvete, O, Baraibar, I, Gonzalez, NS, Zamora, E, Sanz, L, Fariñas-Madrid, L, Brana, I, Gonzalez, M, Ristol, F, Diez-Campelo, M, Alfonso-Pierola, A, Bosch, F, Montoro, J, Valcárcel, D




Ciltacabtagene Autoleucel (Cilta-cel) vs Standard of Care (SOC) In Patients (Pts) With Relapsed/Refractory Multiple Myeloma (MM): CARTITUDE-4 Survival Subgroup Analyses

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Weisel, K, Sidana, S, Martínez-Lopez, J, Khan, AM, Oriol, A, Spencer, A, Dhakal, B, Cohen, YC, Touzeau, C, Dytfeld, D, Einsele, H, San-Miguel, J, Manie, S, Chen, D, Li, K, Benachour, N, Lonardi, C, Ghosh, A, Patel, N, Florendo, E, Harrison, SJ




Long-term progression-free survival benefit with ciltacabtagene autoleucel in standard-risk relapsed / refractory multiple myeloma

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Costa, L, Oriol, A, Dytfeld, D, Manier, S, Voorhees, P, Lin, Y, Htut, M, Roeloffzen, W, Ho, PJ, Shah, UR, Zhao, M, Li, QL, Balogh, A, Li, KTRE, Slaughter, A, Benachour, N, Lonardi, C, Ghosh, A, Sun, HB, Lendvai, N, Lengil, T, Patel, N, Koneru, M, Florendo, E, Costa, O, Mahajan, V, Rodriguez-Otero, P, Strouse, C, Stewart, K, Sidana, S




Clinical benefit of adding pertuzumab in neoadjuvant HER2-positive breast cancer: Response and 5-year survival outcomes

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Anglada, BV, Casado, ACV, Juher, HP, Badia, AP, Paradis, AL, Pujol, ET, Grimalt, BF, Stradella, A, Penabad, SR, García-Tejedor, A, Pla, MJ, Montserrat, AMP, Ojeda, ABL, Pérez, EM, Ortega, R, Sivilla, JLP, Vila, MM, Villaro, GV, Simon, SP, Falo, C




Talquetamab plus Cetrelimab in Patients With Relapsed/ Refractory Multiple Myeloma: Initial Safety and Efficacy Results From the Phase 1b TRIMM-3 Study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Teipel, R, Perrot, A, Touzeau, C, Rodriguez-Otero, P, Oriol, A, Morillo, D, Mckay, J, Sanchez, L, Matous, JV, Baljevic, M, Leleu, X, Weisel, K, Einsele, H, Goldschmidt, H, Berdeja, JG, Gong, J, Vishwamitra, D, Cortes-Selva, D, Hodkinson, B, Sauvageot, N, Gray, KS, Zhang, J, Baig, M, Smit, MD, Daskalakis, N, Jonathan, D, Mateos, MV, Vincent, L, Usmani, SZ




HOMOCYSTEINE AND COBALAMIN SYNTHASE W DOMAIN-CONTAINING PROTEIN 2 (CBWD2) IN ACUTE ISCHEMIC STROKE (AIS) CLOTS

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Sak, NG, Sahin, C, Liu, W, Giraud, A, Messina, P, Bozsak, F, Darcourt, J, Sacchetti, F, Januel, AC, Bellanger, G, Pagola, J, Juega, J, Imamura, H, Ohta, T, Spelle, L, Chalumeau, V, Mircic, U, Stanarcevic, P, Vukasinovic, I, Ribo, M, Sakai, N, Cognard, C, Doyle, K




ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Martínez-Rivera, C, Blanco-Aparicio, M, Casas-Maldonado, F, Lopez, FST, Palop-Cervera, M, Cassini, LF, Sanchez-Trincado, JL, Luzon, E, Nuevo, J, Secall, L, González-Sierra, M, Barragán, CP, Padilla-Galo, A

Background/Objectives: Evidence on the use of biologics in severe eosinophilic asthma (SEA) associated with persistent airflow obstruction (PAO) status and smoking habits is scarce. As these factors could potentially impact real-world benralizumab clinical effects, this study was conceived to provide a deeper understanding of these specific patient subgroups. Methods: This observational, retrospective ORBE II study (NCT04648839) involved 204 adults with uncontrolled SEA treated with…



Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Grau-Pérez, M, Mercader-García, P, Giménez-Arnau, AM, Sanz-Sánchez, T, Ninet, VZ, Guijarro, SC, Miquel, FJM, Salvador, JFS, González-Pérez, R, González, IR, Baldrich, ES, Carrascosa, JM, de Frutos, FJO, Serna, MR, Ortega, MEG, Suárez, CP, Triviño, FJN, Chicharro, P, Andreu, M, Gilo, AS, Rodríguez, JJP, Nieto, MAP, Melé-Ninot, G, Guillén, PS, de la Fuente, EG, Elosua-González, M, Munera-Campos, M, Romero, FT, Descalzo, MA, Borrego, L

Background: The REIDAC (Spanish Registry for Research in Contact Dermatitis) conducts nationwide epidemiological surveillance of contact dermatitis in Spain. Anogenital involvement within REIDAC has not been previously studied. Objectives: To describe the most common diagnoses and update relevant allergens in patients with anogenital lesions referred for patch testing. Methods: We analysed patients who underwent patch testing within REIDAC from 2019 to 2024. Patients were classified into three…



Ciltacabtagene Autoleucel vs Standard of Care in Patients With Relapsed/Refractory Multiple Myeloma: CARTITUDE-4 Survival Subgroup Analyses

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Sidana, S, Martínez-Lopez, J, Khan, A, Oriol, A, Spencer, A, Dhakal, B, Cohen, Y, Touzeau, C, Dytfeld, D, Einsele, H, San-Miguel, J, Manier, S, Chen, DA, Li, K, Benachour, N, Lonardi, C, Ghosh, A, Patel, N, Florendo, E, Harrison, S




Early rescue intervention with daratumumab, pomalidomide and dexamethasone (DPd) in high-risk smoldering myeloma (HR-SMM) patients included in the GEM-CESAR treated with carfilzomib, lenalidomide and dexamethasone (KRd)-autologous stem cell transplantation (ASCT)-krd-rd

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Mateos, MV, Martinez-Lopez, J, González-Calle, V, Perez, MSG, Oriol, A, Jimenez, JL, Reinoso-Segura, M, Tamayo, RR, Rodriguez-Otero, P, Dachs, LR, de la Rubia, J, de Arriba, F, Lakhwani, S, Bargay, J, Gonzalez, AP, Puig, N, Romero, MTC, Paiva, B, Alegre, A, Barrigon, FE, Inigo-Rodriguez, MB, Teruel, A, Palomera, L, García-Mateo, A, Alvarez-Rivas, M, Ocio, E, Creixenti, JBB, Palacios, JJL, San-Miguel, J




Short-duration preoperative endocrine therapy alters molecular profiles to predict favourable outcome in ER+/HER2+ early breast cancer: a POETIC translational study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Sirven, MB, López-Knowles, E, Zhu, XX, Tovey, H, Kilburn, L, Holcombe, C, Skene, A, Robertson, J, Bliss, JM, Alataki, A, Smith, I, Schuster, EF, Dowsett, M, Cheang, MCU

Background: About 15-20% of breast cancers (BC) overexpress Human Epidermal Growth Factor Receptor 2 (HER2+), and 50% of them are also oestrogen receptor positive (ER+). Patients with ER+/HER2+ BC with a limited response to systemic therapies are at an increased risk of relapse, thus understanding the mechanisms of resistance is crucial. This study investigates the changes in gene signature expression (Delta GSE) within ER+/HER2+ tumours and their intrinsic subtype (IS) in response to peri…



Sustained MRD negativity in patients with newly diagnosed multiple myeloma treated with carfilzomib-lenalidomide-dexamethasone with or without isatuximab (phase III IsKia trial).

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Gay, F, Roeloffzen, W, Dimopoulos, MA, Rosiñol, L, van der Klift, M, Oriol, A, Katodritou, E, Wu, KL, Rodríguez-Otero, P, Hajek, R, van Leeuwen-Segarceanu, EM, Zamagni, E, van de Donk, NWCJ, Weisel, KC, Schjesvold, F, Blade, J, Einsele, H, Sonneveld, P, Boccadoro, M, Broijl, A




Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Armario-Hita, JC, Galán-Gutierrez, M, Pereyra-Rodríguez, JJ, Suarez-Pérez, J, Rodríguez-Serna, M, de Frutos, JO, Carrascosa, JM, Serra-Baldrich, E, Figueras-Nar, I, Zaragoza-Ninet, V, Ruiz-Villaverde, R




Prognostic implications of commutational patterns in NPM1-mutated AML receiving intensive treatment. cetlam group study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Galvez, PR, Dominguez, MR, Calabuig, M, Castillo, IM, Puyuelo, A, Salamero, O, Jimenez-Chillon, C, Macias, GR, Sturla, AL, Arnan, M, Reyes, CQ, Equiza, TR, Vives, S, Biosca, C, Calmet, FVL, Matheu, TR, Mayol, AS, Garcia, A, Coll, R, Garrido, A, Esteve, J, Tormo, M




Transcriptional profile associated with clinical outcomes in metastatic hormone-sensitive prostate cancer

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Blasco, NJ, De Herreros, MG, Torras, OR, Mileo, LF, Rodríguez-Carunchio, L, Puigsureda, IT, Aversa, C, Mañas, LF, Padrosa, J, García-Esteve, S, Marín-Aguilera, M, Alatamirano, M, Pous, AF, Rodriguez-Vida, A, Duran, MAC, Costa, SC, Gonzalez, IC, Gorina, MF, González, NS, Gonzalez, BM




Closed-Incision Negative Pressure Therapy: Scoping Review and Multidisciplinary Consensus Recommendations of the Spanish Observatory of Infection in Surgery

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Badia, JM, Rubio-Pérez, I, Morales-Pérez, C, Bueno-Lledo, J, Rodríguez-Lorenzo, LM, Sancho, J, Marín-Peña, O, Lopez, S, Masià, J, Balibrea, JM

Surgical site infections (SSI) and surgical site complications (SSC) significantly impact surgery outcomes, increasing hospital stays and mortality rates, and negatively affecting patients' quality of life. Closed-incision negative pressure therapy (ciNPT) emerged as a prophylactic strategy to reduce these complications. However, its applicability across different surgical procedures remains unclear. A scoping review was conducted to synthesise the available evidence on the use of ciNPT in…



Patient involvement in the design of ALIDHE: a study of ivosidenib plus azacitidine in newly diagnosed IDH1 mutant AML

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Nier, S, Pelouchova, J, Hills, R, Salek, S, Derrien, H, Chatin, S, De La Bigne, AM, Vives, S, Recher, C, Döhner, H, Venditti, A, Vyas, P

Aims: The ALIDHE study aims to supplement previous clinical trial data by evaluating the safety and tolerability of ivosidenib + azacitidine in adult patients with newly diagnosed mutant isocitrate dehydrogenase acute myeloid leukemia (AML). Methods: Notably, this study has been designed in collaboration with patient representatives from the Acute Leukemia Advocates Network (ALAN) at all stages. Patient representatives from ALAN completed a survey and attended workshops to share feedback on the…



EDUCAR PROJECT: EFFICACY AND IMPLEMENTATION OF A MULTICOMPONENT STRATEGY TO IMPROVE THERAPEUTIC ADHERENCE IN RHEUMATOID ARTHRITIS.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Lana, MA, Carmona, L, Sivera, F, González-Alvaro, I, Cano-Garcia, L, Grados, D, Muntalà, LV, Nadales, IP, Ortiz, PJA, Casado, PG, de Blas, IP, Moreno, M, Venegas, JJP, Lora, RMS, Vargas, AIR, Barrio, ID, Sanchez, MD, Llorente, I, Gutierrez, JC, al Mashhadani, N, Courel, LG, Madrid, D, Alberola, NM, Bachiller-Corral, J, Martin, CL, Sanchez, MC, González, ACC, Martín, JMM, Bedoya-Sanchis, D, Garcia-Vicuña, R




Updated efficacy and safety results of JNJ-5322, a novel, next-generation BCMAxGPRC5DxCD3 trispecific antibody, in patients with Relapsed/Refractory multiple myeloma

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Krishnan, A, Kaiser, M, Popat, R, Matous, J, Garfall, A, Vega, G, Perrot, A, Anguille, S, Oriol, A, Kint, N, Caers, J, Usmani, S, Karlin, L, Sanchez, L, Varga, C, Roeloffzen, W, Dachs, LR, Pan, DR, Rodriguez-Otero, P, Mateos, MV, Ishida, T, Fukushima, K, Minnick, P, Smit, MD, Daskalakis, N, Prior, T, Vishwamitra, D, Desantis, E, Nguyen, A, Hilder, B, Weidman, J, Hodin, C, Jonathan, D, Lee, SM, Touzeau, C, Lee, H, van de Donk, NWCJ, Minnema, M




Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Chari, A, van de Donk, NWCJ, Dholaria, B, Weisel, K, Mateos, MV, Goldschmidt, H, Martin, TG, Morillo, D, Reece, D, Rodríguez-Otero, P, Bhutani, M, D'Souza, A, Oriol, A, Rosiñol, L, Bahlis, NJ, Vishwamitra, D, Skerget, S, Verona, RI, Bakshi, K, Kang, LJ, Prior, TJ, Vandenberk, L, Tolbert, J, Lee, SM, Smit, MD, Wäsch, R

Talquetamab, a G protein-coupled receptor class C group 5 member D-targeting bispecific antibody for relapsed/refractory multiple myeloma (R/R MM), plus daratumumab, may lead to deeper and more durable responses than either therapy alone. In the phase 1b TRIMM-2 study, patients with R/R MM (at least 3 previous lines of therapy or double refractory to a proteasome inhibitor and an immunomodulatory drug) received subcutaneous talquetamab 0.4 mg/kg weekly (QW; "QW cohort") or 0.8 mg/kg…



Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: a randomized, multicentre, open-label study by GETECCU

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Llao, J, Mañosa, M, Martín-Arranz, E, Zabana, Y, Navarro-Llavat, M, Téller, M, Garcia-Planella, E, Busquets, D, Monfort, D, Pineda, JR, Gutiérrez, A, Villoria, A, Menchén, L, Bastida, G, García-Alonso, FJ, Rivero, M, Chaparro, M, de Francisco, R, Merino, O, Rodríguez-Lago, I, Acosta, MBD, Rodríguez-Fortúnez, P, Rodríguez-Jiménez, C, Calafat, M, Domènech, E

Background Oral corticosteroids remain the treatment of choice for moderately active ulcerative colitis (UC), achieving clinical remission in 30%-60% of patients.Objective To compare the rates of steroid-free clinical-endoscopic remission at weeks 8 and 54 in patients treated with 3 methyl-prednisolone pulses before oral corticosteroids in moderately active UC versus those only receiving oral corticosteroids.Design Prospective, open, multicentre, randomized, controlled trial. Patients with left…



Temporal trends in overall survival among patients with high-risk MDS: Insights from the spanish MDS registry(RESMD)

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Alfonso-Pierola, A, Beya, MD, Bernal, T, Valcarcel, D, Arnan, M, Amigo, ML, Sanchez-Garcia, J, Melchor, RA, Xicoy, B, Ramos, F, Tormo, M, Bargay, J, Romero, MTC, Arenillas, L, Falantes, JF, Unamunzaga, A, Ramos, LH, Diez-Campelo, M




EZH2 molecular alterations drive micromegakaryocyte expansion in MDS defining a specific high-risk group

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Carrizosa, AM, Beas, F, Gabarrós, M, Acha, P, Torres-Esquius, S, Méndez, J, Landwehr, M, Domingo, A, Mesa, A, Gallur, L, Ortega, M, Zamora, L, Arnan, M, Pomares, H, Tuset, E, Abad, K, Restrepo, J, Fernandez-Serrano, M, Garcia, A, Diaz-Beyá, M, Castaño-Diez, S, Chen, WA, Germing, U, Giagounidis, A, Walter, W, Haferlach, T, Montoro, MJ, Jerez, A, Roue, G, Valcarcel, D, Tutusaus, SS




HIV infection in PrEP users: incidence, epidemiological, clinical and virological characteristics: a multicenter ambispective cohort in Spain (SCOPE study)

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Vera, MDM, Alvarez-López, P, Tato, H, Rial, D, Faro, N, Arcos, MDM, Cancio-Suárez, MR, Pérez, A, Pernas, H, Fernández, S, Broto, C, Ariza-Vioque, E, De Loredo, N, Gonzaléz-Cordón, A, De Lazzari, E, Rivero, A, Llibre, JM, Ambrosioni, J




Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Ramos, D, Francesqui, J, Bollo, E, Villar, A, Florez, P, Balcells, E, Castaño, G, Pinillos-Robles, EJ, Godoy-Mayoral, R, Lopez-Muñiz, B, Soler-Sampere, MJ, Castillo, D, Rafecas-Codern, A, Mariscal-Aguilar, P, Portillo, K, Gomez-Carrera, L, Bonilla, G, Millan-Billi, P, Hernández-González, F, Sellarés, J

Background: Sarcoidosis is a multi-organ granulomatous disease with a variable course. To predict mortality in routine clinical practice is challenging, thus, it is imperative to identify predictors of mortality in pulmonary sarcoidosis to guide therapy and management effectively. This study aims to evaluate predictors of all-cause mortality at 5 years in patients with pulmonary sarcoidosis from a Spanish cohort. Study design: We developed a retrospective, multicentre analysis from the Spanish…



Ozanimod Reduces axonal Damage and CNS-restricted and peripheral blood inflammation in RRMS: Soluble Biomarkers Analysis from AppreZiate RWE Study (NCT05811416)

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
França, LCF, Ruiz, LB, Fernandez, CM, Candeliere, A, Quilez, RB, Calles, C, Tello, CR, Canelo, LB, Codina, OC, Martinez, JM, Bravo, GCA, Gonzáles, JMP, Jimenez, DEB, García-Estévez, DA, Gimenez, FGG, Meca-Lallana, JE, Vilanova, D, Perez, X, Guimerans, LMV




Nutritional and Physical Rehabilitation in Post-Critical Coronavirus Disease 2019 (COVID-19) Ambulatory Patients: The NutriEcoMuscle Study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Joaquín, C, Bretón, I, Ocón-Bretón, MJ, Zabalegui, A, Bellido, D, Martín, PM, Martínez-Olmos, MA, Zugasti, A, Riestra, M, Botella, F, García-Almeida, JM

Background: The prevalence of malnutrition is high in post-intensive care unit (ICU) coronavirus disease 2019 (COVID-19) patients during hospitalization and after hospital discharge. This paper presents prospective results from the NutriEcoMuscle study, a multicenter observational study. The study aimed to evaluate changes in nutritional and functional status in post-ICU COVID-19 patients following nutritional and physical rehabilitation interventions. Secondary aims included assessing…



Ponatinib Monotherapy Following Combination With Chemotherapy in Patients With Newly Diagnosed Ph plus ALL: Phase 3 PhALLCON Post Hoc Subgroup Analysis

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Jabbour, E, Kantarjian, H, Aldoss, I, Montesinos, P, Leonard, J, Gomez-Almaguer, D, Baer, MR, Gambacorti-Passerini, C, Mccloskey, J, Minami, Y, Papayannidis, C, Rocha, V, Rousselot, P, Vachhani, P, Wang, E, Chao, B, Hennessy, M, Vorog, A, Patel, N, Yeh, T, Ribera, JM




Organ-specific transcriptomic signatures in visceral metastases of metastatic hormone-sensitive prostate cancer

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Herreros, MGD, Blasco, NJ, Torras, OR, Mileo, LF, Rodríguez-Carunchio, L, Puigsureda, IT, Aversa, C, Mañas, LF, Padrosa, J, García-Esteve, S, Marin, M, Alatamirano, M, Pous, AF, Rodriguez-Vida, A, Duran, MAC, Costa, SC, Gonzalez, IC, Gorina, MF, González, NS, Gonzalez, BM




Post Hoc Analysis of MRD Negativity After End of Induction in the Phase 3 PhALLCON Trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Aldoss, I, Vachhani, P, Kantarjian, H, Montesinos, P, Leonard, J, Gomez-Almaguer, D, Baer, MR, Gambacorti-Passerini, C, Mccloskey, J, Minami, Y, Papayannidis, C, Rocha, V, Rousselot, P, Wang, ENC, Hennessy, M, Vorog, A, Patel, N, Santasusana, JMR, Jabbour, E




Low versus null HER2 tumour expression in "HER2-negative" breast cancer: long-term outcomes based on phenotypes

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Barco, I, González, C, García-Font, M, Fernández, AG, Fraile, M, Tarroch, X, Morlius, X, Vidal, M, González, S, Mitru, CB, Vallejo, E, Molina, G, Torras, M, Chabrera, C

Background Two new categories of breast cancer (BC) have been proposed among HER2-negative patients: HER2 0 + and HER2-low breast cancer. We combined these two categories with Perou's classification. We aimed to identify potential differences in clinicopathological features and prognosis using a new, unofficial classification: Luminal A HER2 0 + , Luminal A HER2-Low, Luminal B HER2 0 + , Luminal B HER2- Low, Triple Negative HER2 0 + , and Triple Negative HER2-Low. Patients and methods We…



Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Tahara, M, Greil, R, Rischin, D, Harrington, KJ, Burtness, B, de Castro, G, Psyrri, A, Braña, I, Neupane, P, Bratland, A, Fuereder, T, Hughes, BGM, Mesía, R, Ngamphaiboon, N, Rordorf, T, Ishak, WZW, Lin, JX, Gumuscu, B, Lerman, N, Soulières, D

Background: Pembrolizumab monotherapy and pembrolizumab-chemotherapy demonstrated superior overall survival (OS) versus cetuximab-chemotherapy (EXTREME) in the primary analysis of the phase III KEYNOTE-048 study of recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the first-line setting. We report updated data with 5 years of follow-up. Methods: Adults with previously untreated R/M HNSCC incurable by local therapy were randomly assigned 1:1:1 to pembrolizumab,…



Buffers in intravenous solutions: is the source of bicarbonate a source of confusion?

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Ulsamer, A, Betbesé, AJ, Campos-Gomez, A, Centelles, J, Domínguez, E, Iglesias-Serret, D, Lorente-Olazábal, JV, Pérez-Fernández, XL, Sabater-Riera, J, Rigo-Bonnin, R, Kellum, JA

There is a widespread belief that organic sodium salts included in intravenous solutions serve as bicarbonate precursors, and that this mechanism explains their effects on plasma pH. We aimed to explain why the effect of organic anions, such as citrate, acetate, gluconate, and lactate on the acid-base balance is independent of bicarbonate generation. For this purpose, we mainly focused on regional citrate anticoagulation (RCA). The sodium load provided with these buffers and its contribution to…



653. MULTIPLE MYELOMA: CLINICAL AND EPIDEMIOLOGICAL Head-to-head longitudinal comparison of two mass spectrometry-based methods for monitoring monoclonal proteins in multiple myeloma: Analytical and clinical insights from the GEM-CESAR trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Puig, N, Nichols, M, Agullo, C, Castro, S, Martinez-Lopez, J, Perez, MSG, Oriol, A, Tamayo, RR, Rosinol, L, Bargay, J, Gonzalez, AP, Phua, C, Alegre, A, Inigo, MB, de la Rubia, J, Teruel, A, Paricio, M, de Arriba, F, Lakhwani, S, Jimenez, JL, Reinoso-Segura, M, Creixenti, JBB, Palacios, JJL, Cedena, MT, Paiva, B, San-Miguel, J, Louzada, M, Mateos, MV




First-in-Human Study of JNJ-79635322 (JNJ-5322), a Novel Next-Generation Trispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma: Initial Phase 1 Results

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Lee, H, Popat, R, Touzeau, C, Perrot, A, Anguille, S, Oriol, A, Kint, N, Caers, J, Minnema, MC, Kaiser, M, Garfall, A, Matous, J, Sanchez, L, Borogovac, A, Karlin, L, Rosinol, L, Roeloffzen, W, Usmani, S, Varga, C, Pan, D, Ishida, T, Minnick, P, Smit, MD, Daskalakis, N, Prior, T, Krevvata, M, Nguyen, A, Hilder, B, Jonathan, D, Weidman, J, Lee, S, Mateos, MV, Rodriguez-Otero, P, Vega, G, van de Donk, NWCJ




Lessons from the European mpox outbreak: strengthening cohort research for future pandemic preparedness

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Visentin, A, Nazeri, A, Peñalvo, JL, Gorska, A, Davis, RJ, Flett, RL, Simensen, VC, Langeland, N, Gaday, Q, Mirandola, M, Mazzotta, V, Nguyen, LBL, Mothe, B, Van Dijck, C, Meyerhans, A, Boesecke, C, Giaquinto, C, Judd, A, Tacconelli, E

Background: Well-designed cohort studies are crucial for pandemic preparedness, informing evidence-based infection prevention and treatment strategies. Objectives: Following the 2022 mpox outbreak in Europe, this scoping review critically evaluates the design, implementation, and characteristics of cohort studies focusing on mpox. The aim is to inform recommendations for the Cohort Coordination Board and the COordination MEchanism for Cohorts and Trials (CoMeCT) to enhance cohort study research…



AI-based classification and outcome prediction in BCR::ABLI-like B-cell precursor acute lymphoblastic leukemia patients using targeted RNA-seq

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Rosa-Rosa, JM, Ribera, J, Morgades, M, Granada, I, Diaz, RA, Barrera, S, Hernandez-Sanchez, A, Acosta, JDN, Garcia, MH, Such, E, Torrent, A, Coll, R, Cervera, M, Artigal, CM, Rivas, JMH, Orfao, A, Ribera, JM, Martinez-Lopez, J, Sanchez, R




Impact of Radiotherapy and Immune Checkpoint Inhibitor Combination in Advanced NSCLC: Real-World Data (RWD) Analysis

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Bosch-Barrera, J, Pardo, M, Cobo, M, Oliva-Poch, E, Sais, E, Carcereny, E, Rodriguez-Abreu, D, Castro, RL, Vidal, OJ, Sánchez, A, Massuti, B, Padilla, A, Bernabe, R, Campelo, RG, Lázaro, M, Morillo, ED, Ortega, AL, Vázquez, S, Provencio, M




TAVI with the ACURATE neo2 in severe bicuspid aortic valve stenosis: the Neo2 BAV Registry

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Rück, A, Kim, WK, Del Sole, PA, Wagener, M, Mcinerney, A, Yacoub, MS, Hasabo, EA, Ayhan, C, Elzomor, H, Neiroukh, D, Amir, A, Saleh, N, Settergren, M, Lindler, R, Verouhis, D, Sossalla, S, Renker, M, Montorfano, M, Bellini, B, Suarez, XC, Del Olmo, VV, de Marco, F, Biroli, M, Moellmann, H, Enno, EC, Tarantini, G, Fabris, T, Ielasi, A, Costa, G, Barbanti, M, Soliman, O, Mylotte, D

BACKGROUND: The ACURATE neo2 is a contemporary transcatheter aortic valve implantation (TAVI) system approved for the treatment of severe aortic stenosis in Europe. The ACURATE neo2 has not been evaluated in bicuspid aortic valve (BAV) stenosis. AIMS: We sought to evaluate the safety and efficacy of ACURATE neo2 in patients with BAV stenosis. METHODS: We retrospectively analysed consecutive severe BAV stenosis patients undergoing TAVI with ACURATE neo2 at 10 European centres. Imaging data from…



Surgical Outcomes and Oncological Quality of Surgery According to IASLC Criteria in NADIM II Trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Jarabo, JR, Fernández, E, Macia, I, Romero, L, Fraile, CA, Rivas, F, Deniz, C, Blanco, AI, Sánchez, L, Rodrigu, C, Foschini, G, Ascanio, F, Monge, S, Rubio, M, Garcia-Fontán, EM, Villalobos, JL, Blanco, M, Carrasco, R, Gálvez, C, Bolufer, S, Campo-Cañaveral, JL, Crowley, S, Figueroa, S, Wins, R, Galán, G, Marron, C, Romero, A, Ramos, R, Boada, M, Ureña, A, Sánchez, D, Corpa, E, Vicente, R, Partida, C, Delgado, M, de la Torre, M, Mongil, R, Guirao, A, Arrabal, R, Fibla, JJ, Jiménez, U, Lorenzo, M, Pastor, E, Guijarro, R, Cilleruelo, A, Martinez-Barenys, C, Alvarez, A, Provencio, M, Hernando, F




MRD negativity after end of induction in the phase 3 PhALLCON trial: A post hoc analysis.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Aldoss, I, Vachhani, P, Kantarjian, HM, Montesinos, P, Leonard, JT, Gomez-Almaguer, D, Baer, MR, Gambacorti-Passerini, C, McCloskey, JK, Minami, Y, Papayannidis, C, Rocha, VG, Rousselot, P, Wang, ES, Yang, L, Hennessy, M, Vorog, A, Patel, N, Ribera-Santasusana, JM, Jabbour, E




Isatuximab subcutaneous by on-body injector in Relapsed/Refractory multiple myeloma in the Phase 3 iraklia study: Effect of body weight on pharmacokinetics and clinical outcome

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Lu, J, Oriol, A, Berkovits, A, Spencer, A, Gomez, C, Li, CR, Cerchione, C, Li, F, Schjesvold, F, Parmar, G, Spicka, I, Hus, M, Custidiano, MD, Dimopoulos, M, Rajnics, P, Besisik, SK, Ailawadhi, S, Ling, SL, Hungria, V, Leleu, X, Teisserenc, FS, Stefanova-Urena, M, Zhang, RC, Koch, V, Semiond, D




Uncovering combination therapies for Immune-Mediated Inflammatory Diseases through systems biology analysis on longitudinal patient data

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Juli, A, Lasanta, ML, Choy, E, Vela-Casasempere, P, Castañeda, S, Nebro, AF, Calvo-Alén, J, Marras, C, Tornero, J, Cañete, JD, Domènech, E, Gisbert, J, Carrascosa, JM, Fonseca, E, Bujanda, L, García, V, Siegmund, B, Girolomoni, G, Heyn, H, Santamaria, P, Myers, R, Guillen, Y, Martínez-Mateu, SH, Marsal, S




Phase 3 AQUILA Study of Daratumumab Monotherapy Versus Active Monitoring in Patients With High-Risk Smoldering Multiple Myeloma (SMM)

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Dimopoulos, MA, Voorhees, P, Schjesvold, F, Cohen, YC, Hungria, V, Sandhu, I, Lindsay, J, Baker, RI, Suzuki, K, Kosugi, H, Levin, MD, Beksac, M, Stockerl-Goldstein, K, Oriol, A, Mikala, G, Garate, G, Theunissen, K, Spicka, I, Mylin, AK, Bringhen, S, Uttervall, K, Pula, B, Medvedova, E, Cowan, AJ, Moreau, P, Mateos, MV, Goldschmidt, H, Ahmadi, T, Sha, LL, Cortoos, A, Katz, EG, Rousseau, E, Li, L, Dennis, RM, Carson, R, Rajkumar, SV




Characterization and outcomes of patients with indolent Mantle Cell Lymphoma (iMCL) in Spain. the GELTAMO-MCL-2022 Study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Niebla, AM, Gine, E, Bastos-Oreiro, M, Perez, A, Cabirta, A, Vicente, FD, Vilaseca, MC, Ubieto, AJ, De Villambrosia, SG, Prat, AM, Barca, EG, Henriquez, HDL, Herranz, ER, Prieto, PG, Cordoba, R, Carreres, AS, Garcia-Sancho, AM, Moya, AMGN, Grande, C, Martine, PP, Nicolas, C, Gutierrez, A, Rivas, JAH, Sanchez-Gonzalez, B, Villalobos, MT, Garcia-Cerecedo, T, Trillo, RA, Donato, E, Gutierrez, PV, Belmonte, DG, Cozzarelli, SRV, Ordoñez, SS, De La Mano, EP, Avaría, A, Blanco, LV, Roldan-Perez, A, Sancho, JM, De la Cruz, B, Prince-Eladnani, R, Abrisqueta, P




Castleman disease as a spectrum: Characterization of novel subtypes using data from the spanish GELTAMO registry

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Lapietra, G, Mendez, A, Cintas, X, Ubieto, AJ, Gutierrez, A, Garcia-Sancho, AM, Alonso, C, Bastos-Oreiro, M, Vilafuerte-Gutierrez, PS, Barca, EG, Martinez, AR, Matilla, BN, Abrisqueta, P, Garcia, AG, Rivas, JAH, Lopez-Garcia, A, Guillermo, AL, Fernandez, N, Del Campo, R, De La Mano, EP, Sarasa, M, Cañamero, E, Perez, AR, Rodriguez, M, Montes-Moreno, S, Melendo, GT, Navarro, JT




Comparative analysis of NGS and dPCR for measurable residual disease monitoring in intensively treated acute myeloid leukemia patients

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Ramil, G, Artigas, A, Giné, A, Oñate, G, Castellet, H, Díaz-Beyá, M, Tormo, M, Cervera, M, Coll, R, Martínez-Serra, J, Vives, S, García-Guiñón, A, Mascaró, M, Gómez, L, García-Avila, S, Vall-Llovera, F, Gómez, R, Arnan, M, Salamero, O, Garrido, A, Esteve, J, Nomdedéu, J, Sierra, J, Pratcorona, M




EXTERNAL VALIDATION OF TWO PREDICTIVE SCORES FOR HEMORRHAGIC TRANSFORMATION FOLLOWING ENDOVASCULAR THROMBECTOMY IN A POPULATIONBASED STUDY

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Romeu, MD, Guasch, M, Ezcurra, G, Lambea-Gil, A, Ramos-Pachón, A, Martínez-Domeño, A, Prats-Sanchez, L, Fernandez-Vidal, JM, Toscano-Prat, C, Martí-Fàbregas, J, Martínez-González, JP, Fernández-Cadenas, I, Cardona, P, Rodriguez-Villatoro, N, Rodríguez-Vázquez, A, Gomis, M, Xuclà-Ferrarons, T, Rodrìguez-Campello, A, Cánovas, D, Seró, L, Purroy, F, Salvat-Plana, M, Abilleira, S, Camps-Renom, P




Circulating tumor DNA (ctDNA) for minimal disease detection in oropharyngeal cancer (OPC): results from the CAPTION Spanish prospective study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Sepulveda, ZV, Tous, S, Quiros, B, Pena, GP, Castro, JB, Serrahima, MP, Galiana, IL, Marí, A, Brunet, A, Bermejo, JO, Cirauqui, BC, Diez, AF, Leon, X, Sumarroca, A, Giner, M, Clavero, O, Goma, M, Pavon, MA, Alemany, L, Bernal, MO




Real-world outcomes and prognostic factors in older adults with early-stage classic Hodgkin lymphoma: A study from the spanish relinf-geltamo registry

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Munoz, MCM, Cordoba, R, Nunez, RMR, Sánchez-González, B, Moreno, M, Castronuño, DA, Cannata, J, Prieto, PG, Benito, L, Torrado, T, Buch, J, Fernandez-Caldas, P, Gainza, E, Gómez, LAL, González-gascón-y-Marín, I, Carpio, C, Alonso, RS, Arnao, MM, Mora, MRF, Dominguez, SR, Gutiérrez, PV, Maestre, MDGM, Dominguez, N, de la Cru, B, Caballero, JC, Cobo, T, Mahillo, I, Domenech, ED




Linvoseltamab (LINVO) plus carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial results from the LINKER-MM2 trial.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Manier, S, Ocio, EM, Martinez-Chamorro, C, Delimpasi, S, Oriol, A, Dimopoulos, MA, Leleu, XP, Rubinstein, S, Joseph, NS, Mesa, MG, Chakraborty, R, de Larrea, CF, Breazna, A, Drew, J, Boyapati, A, Hazra, A, Kroog, GS, Sarkaria, SM, Rodríguez-Otero, P




Derivation and Validation of a Prediction Model for Long-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: the PREDICT-STEMI Score

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Ortega-Paz, L, Laudani, C, Brugaletta, S, Calés, PV, Solé, AA, Buera, I, Manilla, MC, Carrillo, X, Jimenez, M, Guarinos, J, Camacho, JM, De Diego, O, Tizon-Marcos, H, Querol, CT, Lara, JG, Diaz, VAJ, Jimenez, P, Diletti, R, Bordes, P, Campo, G, Hospital, JAG, Rodes-Cabau, J, Angiolillo, D, Sabate, M




Daratumumab monotherapy versus active monitoring in patients with high-risk smoldering multiple myeloma: Aquila outcomes based on mayo 2018/IMWG 2020 risk stratification, IMWG 2020 plus cytogenetic criteria, and age

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Voorhees, P, Dimopoulos, M, Cohen, Y, Schjesvold, F, Hungria, V, Sandhu, I, Lindsay, J, Baker, R, Suzuki, K, Kosugi, H, Levin, MD, Beksac, M, Stockerl-Goldstein, K, Magen, H, Oriol, A, Mikala, G, Garate, G, Theunissen, K, Spicka, I, Mylin, A, Hallam, S, Bringhen, S, Uttervall, K, Pula, B, Khan, A, Medvedova, E, Ye, JC, Cowan, A, Moreau, P, Mateos, MV, Goldschmidt, H, Vieyra, D, Raval, A, Sha, LL, Li, L, Rousseau, E, Dennis, R, Carson, R, Rajkumar, SV




Territorial Implementation and Evaluation of a Nurse-Led Expert Patient Programme for People with Multiple Sclerosis: Impact on Knowledge, Empowerment, and Health Indicators

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Sanchez, MAR, Amil-Bujan, P, Bosch-Farre, C, Coll-Martinez, C, Arevalo, MJ, Anglada, E, Menedez, R, Alsina, MA, Bravo, G, Arrieta, P, Resina, M, Merchan-Ruiz, M, Perez-Hoyos, S, Arevalo, AG, Montalban, X, Hernando, A, Llufriu, S, Peralta-Moncusi, S, Brieva, L, Ramo-Tello, C, Carabi, M, Sola-Valls, N, Cinta-Zabay, M, MañeMartinez, MA, Pastore, F, Sastre-Garriga, J, Ramio-Torrenta, L, BertranNoguer, C




Ciltacabtagene autoleucel (cilta-cel) vs standard of care (SOC) in patients (pts) with relapsed/refractory multiple myeloma (MM): CARTITUDE-4 survival subgroup analyses.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Sidana, S, Martinez-Lopez, J, Khan, AM, Oriol, A, Spencer, A, Dhakal, B, Cohen, YC, Touzeau, C, Dytfeld, D, Einsele, H, San-Miguel, J, Manier, S, Chen, Y, Li, K, Benachour, N, Lonardi, C, Ghosh, A, Patel, N, Florendo, E, Harrison, SJ




IMPACT OF EARLY NEUROLOGICAL DETERIORATION BEFORE ENDOVASCULAR TREATMENT ON FUNCTIONAL OUTCOMES IN MILD STROKE PATIENTS

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Gómez-Choco, M, Font, MA, Avellaneda-Gomez, C, Boned, S, Mengual, JJ, García-Sánchez, SM, Rosa, I, Millán, M, Cardona, P, Molina, C, Silva, Y, Purroy, F, Camps-Renom, P, Rodríguez-Campello, A, Ustrell, X, Krupinski, J, Cánovas, D, Palomeras, E, Zaragoza-Brunet, J, Cocho, D, Mas, N, Jimenez, FX, Salvat-Plana, M, Abilleira, S




Residential Radon and Molecular Alterations in Non-Small Cell Lung Cancer

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Calvo, V, Gonzalez, LO, Gisbert, LMD, Serna, R, Juan-Vidal, O, del Barco, E, Sala, MA, Medina, K, Areses, K, Antoñanzas, M, Cordero, MG, Martin-Lopez, J, Díaz, A, Guirado, M, Aguiar, D, Saigí, M, Lopez, A, Jimenez, E, Domine, M, Moreno, M, Viteri, S, Rosado, P, Lorduy, AC, Clemente, MB, Martínez, M, Garitaonaindia, Y, Aguado, R, Ospina, AV, Romero, A, Raviña, AR, Provencio, M




Fixed-duration epcoritamab monotherapy induces high response and MRD-negativity rates in elderly patients with newly diagnosed large B-cell lymphoma (LBCL) and comorbidities: Results from EPCORE DLBCL-3

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Vitolo, U, Duell, J, Burgues, JMB, Jurczak, W, Kwiatek, M, Maerevoet, M, Alcaide, SO, Belada, D, Kim, WS, Greil, R, Cordoba, R, Sancho, JM, Sibon, D, Thieblemont, C, Kumode, T, Wielgos-Bonvallet, M, Jiang, TY, Wang, YL, Mcgoldrick, S, Guo, EVY, Morschhauser, F, Woei-A-Jin, S




Study design of A phase 3, open-label trial for pozelimab and cemdisiran combination therapy in patients with paroxysmal nocturnal hemoglobinuria with inadequate control of intravascular hemolysis

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Jang, JH, Lekue, CB, Burgues, JMB, Calado, R, Chang, YC, Czyz, J, Frairia, C, Hernandez, I, Kim, H, Kim, JS, Koh, Y, Marceau, D, Mauad, VAQ, Mun, YC, Park, S, Ramalho, F, Sahin, F, Notaro, R, Sica, S, Yenerel, M, Mitchell, A, Dong, XW, Perlee, L




A bispecific monoclonal antibody targeting Pseudomonas aeruginosa in bronchiectasis: results from the GREAT-2 trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Long, MB, Hull, RC, Gilmour, A, Viligorska, K, Richardson, H, New, JM, Hennayake, C, Galloway, R, Mcintosh, E, Eke, Z, Lind, H, Band, M, Bandara, H, Martin, G, Aliberti, S, Timothy, A, Norwell, J, Whitehouse, J, Addy, CL, Finney, L, Mitchelmore, P, Caskey, SJ, Lord, RW, Hill, AT, Vendrell, M, Polverino, E, Marin, A, Suarez-Cuartin, G, Loebinger, MR, Tunney, M, Cartwright, K, Hughes, R, Digiandomenico, A, Belvisi, MG, Brailsford, W, Haworth, C, Sibila, O, Stobo, J, Chalmers, JD




Lack of association between loneliness, social isolation and inflammation in people living with HIV aged =50 years: Results from the sub-study "No One Alone-Gesida Study"

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Blanco, JR, Albendin-Iglesias, H, Negredo-Puigmal, E, Barrios-Blandino, AM, Tomás-Jimenez, C, Sanjoaquin-Conde, I, Saumoy, M, Pérez-Esquerdo, V, Gonzalez-Cuello, I, Lopez-Lirola, AM, Galindo, MJ, Cabello-Clotet, N, Otero, JA, Merino-Muñoz, D, Cano-Smith, J, Muelas-Fernandez, M, De La Torre, J, González-Baeza, A, Romero, L, Ocampo, A, Torres, R, Hidalgo, C, Esteban, H, Fernandes-Lopez, MA, Puig, J, Fraile, LG, Morell, EB, Perez-Martinez, L, Montero, MD, Jarrin, I, Olalla, J

Introduction Inflammation is linked to multiple health conditions. Emerging evidence suggest it may play a role in the association between social isolation - loneliness and health outcomes. People living with HIV (PLWH) exhibit chronic inflammation even with viral suppression, likely due to ongoing immune activation. However, few studies have explored inflammatory biomarker in PLWH experiencing loneliness or social isolation. This study aimed to assess this association in PLWH aged 50 or older.



Virological non-inferiority and lower weight gain with DTG/3TC versus BIC/FTC/TAF: 96-week final results from the PASO-DOBLE (GeSIDA 11720) randomised, multicentre, openlabel, non-inferiority trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Masia, M, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Garcia-Fraile, L, Blanco, JL, Ryan, P, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, X, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Gil, P, de Miguel, M, Alejos, B, Martinez, E




Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Matthews, R, Armstrong, AW, Augustin, M, Baker, C, Carrascosa, JM, Kirby, B, Langley, R, McBride, S, Reich, A, Romiti, R, Sampogna, F, Warren, RB

IntroductionDelays remain in patients receiving effective treatment strategies that have potential to clear their skin of psoriasis, improve their quality of life (QoL) and change the psoriatic disease course, which, if uncontrolled, can irreversibly alter an individual's life course (i.e. cumulative life course impairment [CLCI]). This study explored current international awareness and consideration of the potential impact of psoriasis over the life course within clinical assessments and…



New Stent Retriever Technology Versus Standard Devices for Anterior Large Vessel Thrombectomy: A Multicenter Study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Puig, J, Dolz, G, Werner, M, Daunis-i-Estadella, P, Comas-Cufí, M, Tomasello, A, González, E, del Caño, XM, Vega, P, Murias, E, Bravo, I, Jiménez, E, Aparici-Robles, F, Sanchís, JM, Remollo, S, Castaño, C, Moreu, M, López-Frías, A, Terceño, M, Silva, Y, Chirife, O, López-Rueda, A, Martínez-Fernández, J, Méndez, JC, Sagredo, A, Díaz-Pérez, J, Cuba, V, Llibre, JC, Aguilar, Y, SanRoman, L, Blasco, J

Background and Purpose: Guidelines recommend stent retrievers (SRs) for treating large vessel occlusion (LVO) stroke. We assessed noninferiority of the iNtercept (iVascular) SR with a self-expanding basket on a pusher wire versus contemporary SRs (CSRs) using propensity score (PS) matching analysis. Methods: We analyzed data from the ROSSETTI multicenter registry of patients with anterior circulation LVO to compare procedural (recanalization rates according to the modified Thrombolysis In…



Thymidine kinase activity (TKa) as independent predictor of outcome in metastatic breast cancer (MBC) patients in the GEICAM/2013-02 PEARL trial.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Guerrero, A, Gil, MJG, Williams, A, Ruiz, M, Ritzen, HS, Ciruelos, EM, Munoz, M, Bermejo, B, Margeli, M, Anton, A, Kahan, Z, Csoszi, T, Murillo, L, Murillo, SM, Lang, IS, Herranz, J, Caballero, R, Fisker, H, Portela, M, Martin, M




Safety and Efficacy of Bromodomain and Extra-Terminal (BET) Inhibitor INCB057643 in Patients With Relapsed or Refractory Myelofibrosis (MF) and Other Advanced Myeloid Neoplasms: A Phase 1 Study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Watts, J, Vannucchi, AM, Hunter, AM, Gupta, V, Tantravahi, SK, Yuda, J, Iurlo, A, Bose, P, Gomez-Casares, T, McMahon, B, Palandri, F, Searle, E, Xicoy, B, Srisuwananukorn, A, Halpern, AB, Diaz, RA, Rivas, JMH, Tomita, A, Burke, L, Zhou, F, Zheng, FD, Vachhani, P




Real World Clinical Data of Persistence, Effectiveness and Safety of Ozanimod Treatment in RRMS Patients in Spain: Interim Analysis of the AppreZiate Study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Ruiz, LB, Guimerans, LMV, Quilez, RB, Garcia-Estévez, DA, Martinez, JM, Calles, C, Fernandez, CM, Candeliere, A, Krupinski, J, Muñoz, PL, Villarrubia, AR, Meca-Lallana, V, Muñoz, IP, Redondo, MG, Tello, CR, Blanco, Y, Meca-Lallana, JE, Gadea, MC, Bravo, GCA, Gonzáles, JMP, Jimenez, DEB, Canelo, LB, Valls, NS, González-Suárez, I, Riancho, J, Codina, OC, Eichau, S, Gimenez, FGG, Torres, EM, Oreja-Guevara, C, Vilanova, D, Perez, X, França, LCF




High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Lahuerta, JJ, San-Miguel, J, Jiménez-Ubieto, A, Alonso, R, Paiva, B, Puig, N, Cedena, MT, Gutierrez, NC, Calasanz, MJ, Guijarro, MF, Tamayo, RR, Rocafiguera, AO, Blanchard, MJ, Cruz, EC, Martínez-Martínez, R, Bargay, J, Balari, AS, de la Rubia, J, García, MTH, Cabañas, V, Montero, FC, Bernal, LP, Montes, YG, Martínez-Lopez, J, Rodriguez-Otero, P, Krisnik, I, Arguiñano, JM, García, MEG, Ocio, EM, de la Cruz, J, Mateos, MV, Rosiñol, L, Bladé, J, Spanish Myeloma Grp

In retrospective studies, autologous stem cell transplantation (ASCT) conditioning with intravenous busulfan and melphalan (BUMEL) led to longer progression-free survival (PFS) than melphalan alone (MEL200). We compared long-term outcomes of BUMEL vs MEL200 in the context of intensified bortezomib, lenalidomide, and dexamethasone (VRD) induction and consolidation therapies. GEM12 was a phase 3 trial for patients with newly diagnosed multiple myeloma (NDMM) eligible for ASCT including 6…



Plasmablastic lymphoma (PBL) comparison between europe-Latin America and validation of the PBL international prognostic index (PBL-IPI): Collaborative study of the lymphoma groups geltamo, gatla and gell

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Martin-Moro, F, Martinez-Cordero, H, Perez, GA, Caballero, JC, Llanes, EO, Ubieto, AJ, Martinez, LMV, Trucco, JI, Gomez-Llobell, M, Orlova, M, Prieto, PG, Guanchiale, L, Alcoceba, M, Arriola, J, Dominguez, SR, Fiad, N, Abrisqueta, P, Pessolani, F, Gutierrez, PV, Gonzalez, AP, Nuñez, MV, Matilla, BN, Huerga, S, Belmonte, DG, Alos, DG, De La Mano, EP, Cannata, J, Macchiavello, E, Laviano, J, Salvano, L, Rocca, M, Barca, EG, Jimenez, JL, Cordoba, R, Sancho, JM, Navarro, JT, Pavlovsky, A, Bastos-Oreiro, M




First-in-human study of JNJ-79635322 (JNJ-5322), a novel, next-generation trispecific antibody (TsAb), in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial phase 1 results.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
van de Donk, NWCJ, Vega, G, Perrot, A, Anguille, S, Oriol, A, Minnema, M, Kaiser, MF, Lee, HC, Garfall, A, Matous, JV, Sanchez, LJ, Borogovac, A, Karlin, L, Usmani, SZ, Weidman, J, Lee, SM, Mateos, MV, Rodríguez-Otero, P, Touzeau, C, Popat, R




Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Butzkueven, H, Farr, P, Ozakbas, S, Boz, C, Kalincik, T, Taylor, L, Van Der Walt, A, Alroughani, R, Buzzard, K, Skibina, O, Lechner-Scott, J, Laureys, G, Terzi, M, Van Pesch, V, Grand-Maison, F, Barnett, M, Kermode, A, Menoyo, JLS, Rojas, J, Willekens, B, Foschi, M, Ramo-Tello, C, Skromne, E, Dirks, P, Muros-Le Rouzic, E, Spelman, T

Introduction: The MSOCR-R study evaluates the long-term effectiveness of ocrelizumab (OCR) in patients with relapsing multiple sclerosis (RMS) in real-world clinical settings. Methods: MSOCR-R is an ongoing, prospective, longitudinal, observational cohort study of people with RMS newly treated with OCR, using data from the international MSBase registry. The study started in July 2018, and data collected up to October 2023 were analyzed. Outcomes were confirmed disability worsening (CDW),…



Clinical impact of FLT3 microclones on outcomes in patients with newly diagnosed FLT3-ITD negative AML: A subanalysis from the pethema quiwi trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Sargas, C, Boudry, A, Madrid, PL, Duployez, N, Barragán, E, Diaz, RA, Colmenares, R, Chillon, C, Calasanz, M, Larrayoz, MJ, Veiga, RR, Burgues, JMB, Algarra, L, Botella, C, Rodriguez-Arboli, E, Del Castillo, TB, Tormo, M, Calbacho, M, Salamero, O, Serrano, J, Concepción, VN, López-López, JA, Vives, S, Lorenzo, JLL, Colorado, M, Vidriales, MB, Garcia-Boyero, R, Rubio, MTO, Puente, PH, Arce-Fernández, O, Garcia, MB, Martinez-Cuadron, D, Labrador, J, Preudhomme, C, Montesinos, P




Additional efficacy and safety outcomes and an exploratory analysis of the impact of pathological complete response (pCR) on long-term outcomes from NIAGARA.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Galsky, MD, Van Der Heijden, MS, Catto, JWF, Al-Ahmadie, H, Meeks, JJ, Nishiyama, H, Drakaki, A, Vu, TQ, Antonuzzo, L, Atduev, V, Kann, AG, Kim, TH, Pous, AF, Chang, CH, De Wit, R, Wojtukiewicz, MZ, Xin, WJ, Donegan, SE, Hois, S, Powles, T




Efficacy of extended infusion of (3-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomized, multicentre, open-label, superiority clinical trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Laporte-Amargos, J, Carmona-Torre, F, Huguet, M, Puerta-Alcalde, P, Rigo-Bonnin, R, Ulldemolins, M, Arnan, M, Pozo, JLD, Torrent, A, Garcia-Vidal, C, Pallarès, N, Tebé, C, Muñoz, C, Tubau, F, Padullés, A, Sureda, AM, Carratalà, J, Gudiol, C

Objectives: The efficacy of extended infusions (EI) of (3-lactam antibiotics for optimising outcomes in febrile neutropenia is unclear. We assessed whether the administration of (3-lactams was more effective in EI than in intermittent infusion (II) for the treatment of febrile neutropenia. Methods: We performed a randomized, open-label, superiority clinical trial of patients with febrile neutropenia at four Spanish university hospitals. Patients undergoing haematopoietic stem cell…



European multicenter study on the use of anti-CGRP monoclonal antibodies in migraine: The 2-year follow-up

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Caronna, E, Canales, J, Dorado, L, Escudero, RA, Martins, IP, Sundal, C, Sieira, PI, Ros, AL, Gago-Viega, A, Juanes, FV, Ruscheweyh, R, Sacco, S, Garcia-Azorin, D, Pascual, J, Gil-Gouveia, R, Villanueva, MH, Rodriguez-Vico, J, Lasaosa, SS, Ghadiri-Sani, M, De Icco, R, Ter n, JDD, Insa, SD, Oria, CG, Barbanti, P, Pozo-Rosich, P




ALIDHE: An ongoing open-label phase 3b study investigating ivosidenib with azacitidine in clinical practice in adult patients with newly diagnosed mutant isocitrate dehydrogenase 1 (mIDH1) Acute Myeloid Leukemia (AML) ineligible for intensive induction chemotherapy (IC)

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Vyas, P, Recher, C, Döhner, H, Venditti, A, Salek, S, Nier, S, Boluda, B, Requena, GA, Prince-Eladnani, R, Borlenghi, E, Curti, A, Theunissen, K, Puyuelo, A, Rus, IC, De Leeuw, D, Ammatuna, E, Saini, L, Maertens, J, Schuh, A, Camanho, D, Sullivan, A, de la Bigne, AM, Romagnoli, M, Cognet, B, DiNardo, C, Vives, S




ARIAN, Adjuvant Treatment With Sacituzumab and ZimberelimAb in Resected Patients: A Phase III Study-Trial in Progress

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Provencio, M, Aguiar, D, Antoñanzas, M, Areses, MC, Azkárate, A, Barba, A, Bernabé, R, Blanco, R, Borregon, M, Campos, B, Coves, J, De Castro, J, Domènech, M, Domine, M, Campelo, RG, Gozálvez, CL, Huidobro, G, Insa, A, Juan-Vidal, O, Castro, RL, Martínez-Marti, A, Medina, S, Moreno, MA, Nadal, E, Olivares, A, Reguart, N, Sala, MA, Medina, K, Vilà, L, Massuti, B




VEXAS SYNDROME IN RHEUMATOLOGY: 47 CASES FROM VEXASSER STUDY GROUP

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Garcia-Escudero, P, Gomez, ML, Magallares, BP, Santos, DD, Dorta, AG, de Miera, FJTS, Frade-Sosa, B, Lizarzaburu, MS, Rua-Figueroa, IJ, Suarez, DVF, Melero-Gonzalez, RB, Fillloy, JAM, Belando, CG, Oporto, GB, Boteanu, A, Corrales-Selaya, C, Bolado, IM, Aurrecoechea, E, Santos, CS, Ibanez, M, Font-Urgelles, J, Alonso, ER, Trallero, E, Vazquez-Gomez, I, Casasempere, PV, Roman, AR, Dubuc, CAE, Castaneda, S, Argumanez, CM, Monjo-Henry, I, Laguna, MR, Merayo, EE, Carrion-Barbera, I, Reina, D, Beriain, JAH, Alen, JC




Real-world outcomes after immunotherapy discontinuation in advanced melanoma: Insights from the GEM1801 study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Muñoz-Couselo, E, Berciano-Guerrero, MA, Crespo, G, Castaño, AG, Manzano, JL, Miguel, PAD, Rosa, CA, Cerezuela-Fuentes, P, Puértolas, T, Sanz, LG, Medina, J, Cunquero-Tomás, A, Majem, M, Fernández, LA, Espinosa, E, Bellido, L, Soria, A, Bujosa, A, Algarra, SM, Marquez-Rodas, I




Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Miro, JM, Torres, F, Manzardo, C, Bonfill, E, Curran, A, Domingo, P, Podzamczer, D, Paredes, R, Force, L, Falco, V, Gutierrez, M, Saumoy, M, Castelli, A, Inciarte, A, Rovira, C, Cruceta, A, Hurtado, C, Climent, N, Lozano, F, Plana, M

Objectives: The aim of this trial was to compare the immune reconstitution, virologic response, and safety of dolutegravir (DTG) vs. darunavir (DRV) boosted-based antiretroviral (ART) regimens in very advanced HIV patients. Methods: Phase IV, randomized (1:1 ratio), open-label trial, including adult (>= 18 years) ART-na & iuml;ve HIV-1+ patients with CD4+ cell counts <100 cells/pL from nine hospitals in Spain. Participants were randomized to lamivudine (3TC)/abacavir (ABC)/DTG (DTG…



ReTAVI Registry: Early Outcomes of Redo-TAVI with SAPIEN Platform in a Real-World Prospective Cohort

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Tarantini, G, Fovino, LN, Covarrubias, HA, Wolny, R, Fabris, T, Nawara-Skipirzepa, J, Eden, M, Gomez, JLZ, Joner, M, Cuisset, T, Delgado, V, Rodés-Cabau, J, Saia, F, Bieliauskas, G, Van Belle, E, Modine, T, Rheude, T, Garot, P, Jung, CS, Rudolph, T, Leroux, L, Rottbauer, W, Nestelberger, T, Lhermusier, T, Nejjari, M, Regueiro, A, Meier, D, Fraccaro, C, Hartikainen, TS, Karam, N, Swaans, M, Rodrigues, JA, Dreger, H, Hengstenberg, C, Choudhury, D, Mauler-Wittwer, S, Piazza, N, Combaret, N, Letocart, V, Auffret, V, Durand, E, Urena, M, Del Valle, R, Drago, A, De Carlo, M, Diaz, VAJ, Dabrowski, M, Mascherbauer, J, Sudre, A, Ong, P, Gonska, B, Mancone, M, Fabris, E, Teles, R, Nombela-Franco, L, Asmarats, L, Vilalta, V, Protasiewicz, M, Webb, J, Toth, G, Zierer, A, Rioufol, G, Seiffert, M, Adamo, M, Meucci, F, Ielasi, A, Burzotta, F, Lopez, M, Loewenstein, I, Kralisz, P, Legutko, J, Huczek, Z, Pavei, A, Rakova, R, Wesselink, W, Zielinski, M, Greinert, D, Trushina, N, Zimmermann, L, Bramlage, P, Parma, R